SCHEMBL7676136

SCHEMBL7676136

CSc1nccc(-c2nccnc2-c2cccc(C(F)(F)F)c2)n1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 11/20 0.50
LMNA P02545 1/20 0.47
KMO O15229 1/20 0.46
TDO2 P48775 1/20 0.44
ALDH1A1 P00352 1/20 0.40
GAA P10253 1/20 0.40
ATM Q13315 1/20 0.40
CSNK1A1 P48729 1/20 0.40
CSNK1D P48730 1/20 0.40
RPS6KA3 P51812 1/20 0.40
DYRK3 O43781 1/20 0.40
CCNT1 O60563 1/20 0.40
CCNA2 P20248 1/20 0.40
CDK2 P24941 1/20 0.40
CDK9 P50750 1/20 0.40
CDK5 Q00535 1/20 0.40
DYRK1A Q13627 1/20 0.40
CDK5R1 Q15078 1/20 0.40
DYRK2 Q92630 1/20 0.40
DYRK1B Q9Y463 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11467792 0.88 LMNA (0.58) MAPK14LMNAKMOALDH1A1GAA
SCHEMBL5813593 0.82 MAPK14 (0.46) MAPK14LMNAKMOTDO2CSNK1A1
SCHEMBL7222330 0.82 MAPK14 (0.52) MAPK14LMNAKMOADORA2AADORA1
SCHEMBL5812149 0.81 MAPK14 (0.44) MAPK14LMNAKMOTDO2DYRK3
SCHEMBL5817815 0.81 MAPK14 (0.44) MAPK14LMNAKMOADORA2AADORA1
SCHEMBL6999911 0.81 MAPK14 (0.47) MAPK14LMNAKMOADORA2AADORA1
SCHEMBL7215845 0.79 MAPK14 (0.63) MAPK14LMNAKMOCSNK1DADORA2A
SCHEMBL14561099 0.78 MAPK14 (0.49) MAPK14LMNAALDH1A1CCNA2CDK2
SCHEMBL14561096 0.78 MAPK14 (0.47) MAPK14LMNAKMOALDH1A1GAA
SCHEMBL5410735 0.78 MAPK14 (0.54) MAPK14LMNAKMOALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6350744-B1 PYRMIDINE OR PYRIDINE DERIVATIVES; ANTIARTHRITIC AND ANTIINFLAMMATORY AGENTS; CACHEXIA TREATMENT; INTERLEUKIN AND TUMOR NECROSIS FACTOR INHIBITORS MERCK & CO., INC. 2002-02-26 US disclosed